Christopher G. Holland - 01 Jul 2022 Form 4 Insider Report for Electromed, Inc. (ELMD)

Reporting relationship: Chief Commercial Officer
Issuer ticker: ELMD
Reported as of: 01 Jul 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jul 2022, 19:50:39 UTC
Prior SEC filing: 25 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Joshua L. Colburn, Attorney-in-Fact

Key filing fact

Christopher G. Holland filed Form 4 for Electromed, Inc. (ELMD) on 06 Jul 2022.

Key facts

This page summarizes Christopher G. Holland's Form 4 filing for Electromed, Inc. (ELMD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jul 2022, 19:50.

Change

Previous filing in this sequence was filed on 25 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELMD transaction

Common Stock

Award

Transaction value: $0
Shares: +7,400
Change %: +135%
Price: $0.000000
Shares after: 12,900
Date: 01 Jul 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELMD transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +8,800
Change %
Price: $0.000000
Shares after: 8,800
Date: 01 Jul 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,800
Exercise price: $9.90
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Stock options scheduled to vest in substantially equal increments on each of June 30, 2023, 2024 and 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .